These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19467368)

  • 1. A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy.
    Carruthers A; Carruthers J
    J Am Acad Dermatol; 2009 Jun; 60(6):972-9. PubMed ID: 19467368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.
    Carruthers J; Carruthers A
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S10-7. PubMed ID: 17241408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM;
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
    Chajchir I; Modi P; Chajchir A
    Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.
    Relja M; Poole AC; Schoenen J; Pascual J; Lei X; Thompson C;
    Cephalalgia; 2007 Jun; 27(6):492-503. PubMed ID: 17428299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM; Schim JD; Chippendale TJ
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids.
    de Boulle K
    J Cosmet Laser Ther; 2008 Jun; 10(2):87-92. PubMed ID: 18569261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose.
    Monheit G; Carruthers A; Brandt F; Rand R
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S51-9. PubMed ID: 17241415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes.
    Carruthers A; Carruthers J
    J Drugs Dermatol; 2009 Oct; 8(10):924-9. PubMed ID: 19852121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study.
    Cliff SH; Judodihardjo H; Eltringham E
    J Cosmet Dermatol; 2008 Mar; 7(1):50-4. PubMed ID: 18254812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B; Rzany BJ; Grover R
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type a in the treatment of dermatochalasis: an open-label, randomized, dose-comparison study.
    Cohen JL; Dayan SH
    J Drugs Dermatol; 2006; 5(7):596-601. PubMed ID: 16865863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
    Hantash BM; Gladstone HB
    Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
    Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.
    Silberstein SD; Göbel H; Jensen R; Elkind AH; Degryse R; Walcott JM; Turkel C
    Cephalalgia; 2006 Jul; 26(7):790-800. PubMed ID: 16776693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.
    Ascher B; Zakine B; Kestemont P; Baspeyras M; Bougara A; Santini J
    J Am Acad Dermatol; 2004 Aug; 51(2):223-33. PubMed ID: 15280841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.